Reshape Lifesciences Stock Widgets and Gadgets
RSLS Stock | USD 5.55 0.03 0.54% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- RSLS ReShape Lifesciences
- Latest Disposition of 2699 shares by Bandy Barton P. of ReShape Lifesciences at 0.96 subject to Rule 16b-3
- RSLS 5.55 -0.03
- Low 5.34
- High 5.88
- Volume 30.5 K
- Alpha -0.64
- Beta 0.27
- Return On Equity -1.85
- Return On Asset -0.63
- Profit Margin (1.12) %
- Operating Margin (1.05) %
- Current Valuation 3.04 M
- Shares Outstanding 712.68 K
- Shares Owned By Insiders 5.57 %
- Shares Owned By Institutions 1.83 %
- Number Of Shares Shorted 25.01 K
- Price To Book 2.42 X
- Price To Sales 0.49 X
- Revenue 8.68 M
- Gross Profit 6.8 M
- EBITDA (14.48 M)
- Net Income (11.39 M)
- Cash And Equivalents 11.49 M
- Cash Per Share 0.51 X
- Total Debt 262 K
- Debt To Equity 0.01 %
- Current Ratio 2.12 X
- Book Value Per Share 16.48 X
- Cash Flow From Operations (16.96 M)
- Short Ratio 0.22 X
- Earnings Per Share 76.20 X
- Price To Earnings To Growth (12.12) X
- Target Price 1.0
- Number Of Employees 29
- Beta 1.35
- Market Capitalization 3.64 M
- Total Asset 10.66 M
- Retained Earnings (635.57 M)
- Working Capital 6.52 M
- Net Asset 10.66 M
- Accumulation Distribution 2801.48
- Daily Balance Of Power (0.06)
- Rate Of Daily Change 0.99
- Day Median Price 5.61
- Day Typical Price 5.59
- Price Action Indicator (0.07)
- Period Momentum Indicator (0.03)
- Relative Strength Index 39.02
Market Snapshot Widget Example
DAX Index Germany | 19,323 0.92 | |
Taiwan Weighted Taiwan | 22,904 1.55 | |
PSI 20 Stock Portugal | 6,409 0.76 | |
CROBEX Croatia | 3,118 0.21 | |
Budapest SE Hungary | 79,552 0.41 | |
IDX 30 Jakarta Indonesia | 448.67 1.38 | |
ISEQ 20 Price Ireland | 1,611 0.16 | |
NYSE Comp USA | 20,123 0.78 | |
Tel Aviv 35 Israel | 2,260 0.33 | |
Coreshares Index Tracker South Afric | 1,101 1.57 | |
IPC MEXICO Mexico | 50,437 0.53 | |
KL Technology Malaysia | 59.16 0.08 | |
IBEX 35 Index Spain | 11,657 0.39 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,533 0.22 | |
SPASX Dividend Opportunities Australia | 1,702 1.08 | |
HNX 30 Vietnam | 467.97 0.39 | |
Bucharest BET-NG Romania | 1,209 0.91 | |
AMS Small Cap Netherlands | 1,183 0.81 | |
Oslo Exchange Mutual Norway | 1,422 0.44 | |
BEL Small Belgium | 8,105 0.52 | |
Basic Materials Brazil | 5,762 1.29 | |
Swiss Leader Price Switzerland | 1,932 1.13 | |
Fondo Mutuo ETF Chile | 1,374 0.04 | |
Athens General Comp Greece | 1,402 0.28 | |
Stock Exchange Of Thailand | 1,446 0.41 | |
PX Prague Stock Czech Repub | 1,688 0.17 | |
THE PHILIPPINE STOCK Philippines | 6,780 1.21 | |
WIG 30 Poland | 2,814 0.77 | |
BIST Electricity Turkey | 489.48 1.78 |
Investing Ideas
In addition to having ReShape Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare ReShape Lifesciences
Compare ReShape Lifesciences To Peers
Additional Tools for ReShape Stock Analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.